AR088943A1 - Acido 2-[(3,5-difluoro-3-metoxi-1,1-bifenil-4-il)amino]nicotinico para el tratamiento de psoriasis - Google Patents
Acido 2-[(3,5-difluoro-3-metoxi-1,1-bifenil-4-il)amino]nicotinico para el tratamiento de psoriasisInfo
- Publication number
- AR088943A1 AR088943A1 ARP120104381A ARP120104381A AR088943A1 AR 088943 A1 AR088943 A1 AR 088943A1 AR P120104381 A ARP120104381 A AR P120104381A AR P120104381 A ARP120104381 A AR P120104381A AR 088943 A1 AR088943 A1 AR 088943A1
- Authority
- AR
- Argentina
- Prior art keywords
- difluoro
- psoriasis
- amino
- treatment
- nicotinico
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Abstract
La presente proporciona ácido 2-[(3,5-difluoro-3-metoxi-1,1-bifenil-4-il)amino]nicotínico, o una sal farmacéuticamente aceptable o N-óxido o solvato o derivado deuterado del mismo, para uso en el tratamiento de psoriasis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11382356.1A EP2594271A1 (en) | 2011-11-21 | 2011-11-21 | 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid for the treatment of psoriasis. |
Publications (1)
Publication Number | Publication Date |
---|---|
AR088943A1 true AR088943A1 (es) | 2014-07-16 |
Family
ID=45349113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP120104381A AR088943A1 (es) | 2011-11-21 | 2012-11-21 | Acido 2-[(3,5-difluoro-3-metoxi-1,1-bifenil-4-il)amino]nicotinico para el tratamiento de psoriasis |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2594271A1 (es) |
AR (1) | AR088943A1 (es) |
WO (1) | WO2013076170A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11311548B2 (en) | 2017-03-02 | 2022-04-26 | Aslan Pharmaceuticals Pte. Ltd. | Cancer therapy |
TW201834649A (zh) * | 2017-03-02 | 2018-10-01 | 新加坡商亞獅康私人有限公司 | 癌症療法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2319596B1 (es) | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
EP2135610A1 (en) * | 2008-06-20 | 2009-12-23 | Laboratorios Almirall, S.A. | Combination comprising DHODH inhibitors and methotrexate |
EP2228367A1 (en) | 2009-03-13 | 2010-09-15 | Almirall, S.A. | Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors |
-
2011
- 2011-11-21 EP EP11382356.1A patent/EP2594271A1/en not_active Withdrawn
-
2012
- 2012-11-21 AR ARP120104381A patent/AR088943A1/es not_active Application Discontinuation
- 2012-11-21 WO PCT/EP2012/073278 patent/WO2013076170A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2013076170A1 (en) | 2013-05-30 |
EP2594271A1 (en) | 2013-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120318T1 (el) | Υποκατεστημενες βενζυλινδαζολες για χρηση ως αναστολεις κινασης bub1 στη θεραπευτικη αντιμετωπιση υπερπολλαπλασιαστικων ασθενειων | |
CY1120334T1 (el) | Υποκατεστημενης 3-αλλογονοαλυλαμινης αναστολεις ssao και χρησεις αυτων | |
CY1118340T1 (el) | Αναστολεις κινασης | |
CY1119490T1 (el) | Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων | |
CY1120832T1 (el) | Τροποποιητες πυρηνικης μεταφορας και χρησεις αυτων | |
CY1121150T1 (el) | Νευροδραστικα 19-αλκοξυ-17-υποκατεστημενα στεροειδη, χρησιμα σε μεθοδους θεραπειας | |
CY1119798T1 (el) | Μορφη iv υδροχλωρικης ιβαμπραδινης | |
MX345928B (es) | Composiciones terapeuticamente activas y metodos de uso de las mismas. | |
WO2014179564A8 (en) | Thiazolopyrrolidine inhibitors of ror-gamma | |
CY1122006T1 (el) | Παραγωγα προφαρμακου του (ε)-ν-μεθυλο-ν-((3-μεθυλοβενζοφουραν-2-υλο)μεθυλο)-3-(7-οξο-5,6,7,8-τετραϋδρο-1,8-ναφθυριδιν-3-υλο)ακρυλαμιδιου | |
CO6680717A2 (es) | Derivados de quinolina y quinoxalina como inhibidores de cinasa | |
GT201300234A (es) | Sales de 2,3-dihidroimidazo[1,2-c]quinazolina sustituida | |
GT201500053A (es) | Composicion farmaceutica recubierta que contiene regorafenib | |
UY33863A (es) | Metodos y medicamentos para el tratamiento de la enfermedad de alzheimer | |
AR103680A1 (es) | Inhibidores selectivos de bace1 | |
DOP2014000018A (es) | Nuevo derivado de 1,2,3,4-tetrahidroquinolina útil para el tratamiento de diabetes | |
EA201100358A1 (ru) | Дабигатран для чрескожной хирургической катетеризации сердца | |
BR112015017519A2 (pt) | compostos e métodos para o tratamento de infecções bacterianas | |
CO6561789A2 (es) | Método de tratamiento | |
EA201491227A1 (ru) | Новые производные морфолинила, подходящие для применения в качестве ингибиторов mogat-2 | |
CU20110108A7 (es) | [4-(1-amino-etil)-ciclohexil]-metil-aminas como antibacterianos | |
UA109804C2 (xx) | 2-метоксипіридин-4-ільні похідні | |
AR088943A1 (es) | Acido 2-[(3,5-difluoro-3-metoxi-1,1-bifenil-4-il)amino]nicotinico para el tratamiento de psoriasis | |
AU2012307449A8 (en) | Sulfonic acid salts of heterocyclylamide-substituted imidazoles | |
DOP2013000206A (es) | Inhibidores de la peptido desformilasa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |